Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Dominic Magirr · SciRah

Researcher profile · Semantic Scholar

Dominic Magirr

Share profile

Dominic Magirr — researcher profile on SciRah

h-index: 10
Works: 32
Citations: 647

Most-cited papers

A generalized Dunnett Test for Multi-arm Multi-stage Clinical Studies with Treatment Selection
Dominic Magirr, T. Jaki, J. Whitehead
2012154 citations Open access
Semantic Scholar
Some recommendations for multi-arm multi-stage trials
J. Wason, Dominic Magirr, Martin Law, T. Jaki
2012Statistical Methods in Medical Research99 citations Open access
Semantic Scholar
On model-based time trend adjustments in platform trials with non-concurrent controls
Marta Bofill Roig, P. Krotka, C. Burman, E. Glimm +8 more
2021BMC Medical Research Methodology58 citations Open access
Semantic Scholar
Modestly weighted logrank tests
Dominic Magirr, C. Burman
2018Statistics in Medicine56 citations Open access
Semantic Scholar
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
Dominic Magirr, T. Jaki, F. Koenig, M. Posch
2016PLoS ONE50 citations Open access
Semantic Scholar
Flexible sequential designs for multi‐arm clinical trials
Dominic Magirr, Nigel Stallard, T. Jaki
2014Statistics in Medicine37 citations Open access
Semantic Scholar
The R Package MAMS for Designing Multi-Arm Multi-Stage Clinical Trials
T. Jaki, P. Pallmann, Dominic Magirr
2019Journal of Statistical Software35 citations Open access
Semantic Scholar
Considerations on covariates and endpoints in multi‐arm multi‐stage clinical trials selecting all promising treatments
T. Jaki, Dominic Magirr
2013Statistics in Medicine33 citations
Semantic Scholar
Simultaneous confidence intervals that are compatible with closed testing in adaptive designs
Dominic Magirr, T. Jaki, M. Posch, Florian Klinglmueller
2013Biometrika29 citations Open access
Semantic Scholar
Non‐proportional hazards in immuno‐oncology: Is an old perspective needed?
Dominic Magirr
2020Pharmaceutical statistics26 citations Open access
Semantic Scholar
Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels
M. Żebrowska, M. Posch, Dominic Magirr
2015Statistics in Medicine10 citations Open access
Semantic Scholar
The Strong Null Hypothesis and the MaxCombo Test: Comment on “Robust Design and Analysis of Clinical Trials with Nonproportional Hazards: A Straw Man Guidance form a Cross-Pharma Working Group.”
Dominic Magirr, C. Burman
2021Statistics in Biopharmaceutical Research9 citations
Semantic Scholar
NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls
P. Krotka, Katharina Hees, P. Jacko, Dominic Magirr +2 more
2023SoftwareX8 citations Open access
Semantic Scholar
Design and analysis of group-sequential clinical trials based on a modestly weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidance
Dominic Magirr, J. L. Jiménez
2021Clinical Trials8 citations Open access
Semantic Scholar
The MaxCombo Test Severely Violates the Type I Error Rate.
Dominic Magirr, C. Burman
2023JAMA Oncology5 citations
Semantic Scholar
Optimized multiple testing procedures for nested sub-populations based on a continuous biomarker
A. Graf, Dominic Magirr, A. Dmitrienko, M. Posch
2020Statistical Methods in Medical Research5 citations
Semantic Scholar
Block response‐adaptive randomization in clinical trials with binary endpoints
Dominic Magirr
2011Pharmaceutical statistics5 citations
Semantic Scholar
Treatment-Control Comparisons in Platform Trials Including Non-Concurrent Controls
Marta Bofill Roig, P. Krotka, Katharina Hees, Franz König +4 more
2024Statistics in Biopharmaceutical Research4 citations Open access
Semantic Scholar
Phase I study of orally administered 14Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignancies
Alexander MacDonald, G. Scarfe, Dominic Magirr, T. Sarvotham +3 more
2019Cancer Chemotherapy and Pharmacology4 citations
Semantic Scholar
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9‐mediated dose requirements of vitamin K antagonist therapy: a pilot study
Sophie Brunner-Ziegler, B. Jilma, Dominic Magirr, R. Sunder-Plassmann +6 more
2014British Journal of Haematology4 citations Open access
Semantic Scholar
Estimating the Variance of Covariate‐Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary Endpoints
Dominic Magirr, Craig Wang, A. Przybylski, Mark Baillie
2025Pharmaceutical statistics3 citations
Semantic Scholar
Robust Modestly Weighted Log‐Rank Tests
Dominic Magirr, F. Öhrn
2024Pharmaceutical statistics2 citations Open access
Semantic Scholar
Visualizing hypothesis tests in survival analysis under anticipated delayed effects
Jos'e L. Jim'enez, Isobel Barrott, Francesca Gasperoni, Dominic Magirr
2023Pharmaceutical statistics2 citations Open access
Semantic Scholar
Generalizing boundaries for triangular designs, and efficacy estimation at extended follow-ups
A. Allison, T. Edwards, R. Omollo, F. Alves +2 more
2015Trials2 citations Open access
Semantic Scholar
Adaptive Survival Trials
Dominic Magirr, T. Jaki, F. Koenig, M. Posch
20142 citations
Semantic Scholar
How to interpret hazard ratios
Jonathan W. Bartlett, Dominic Magirr, T. Morris
20261 citations
Semantic Scholar
Confidence intervals for two-stage adaptive designs with subpopulation selection
Enyu Li, Nigel Stallard, E. Glimm, Dominic Magirr +9 more
20261 citations
Semantic Scholar
Finite-sample correction for the covariate-adjusted log-rank test
P. Krotka, Dominic Magirr
20260 citations
Semantic Scholar
Efficiency of nonparametric superiority tests based on restricted mean survival time versus the log-rank test under proportional hazards
Dominic Magirr, Craig Wang, Xinlei Deng, T. Morris +1 more
20240 citations
Semantic Scholar
Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves
Dominic Magirr, J. L. Jiménez
2022Biometrical journal. Biometrische Zeitschrift0 citations Open access
Semantic Scholar
Efficacy Evaluation in the Era of Precision Medicine: The Scope for AI
Dominic Magirr
2020Artificial Intelligence in Oncology Drug Discovery and Development0 citations Open access
Semantic Scholar
Treatment selection in multi-arm, multi-stage clinical trials
T. Jaki, Dominic Magirr, N. Stallard
2013Trials0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Jaki×9
Invite
T. Jaki — researcher profile on SciRah
M. Posch×6
Invite
M. Posch — researcher profile on SciRah
P. Krotka×4
Invite
P. Krotka — researcher profile on SciRah
C. Burman×4
Invite
C. Burman — researcher profile on SciRah

×3

Invite

F. Koenig — researcher profile on SciRah

Marta Bofill Roig×2

Invite

Marta Bofill Roig — researcher profile on SciRah

Invite

E. Glimm — researcher profile on SciRah

Katharina Hees×2

Invite

Katharina Hees — researcher profile on SciRah

Invite

P. Jacko — researcher profile on SciRah

J. L. Jiménez×2

Invite

J. L. Jiménez — researcher profile on SciRah

Invite

Craig Wang — researcher profile on SciRah

Mark Baillie×2

Invite

Mark Baillie — researcher profile on SciRah